Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Trump may be mystery patient in odd case of 79yo getting experimental obesity drug" is generating significant coverage in the Business category, with 9 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The New Republic, The Daily Beast, Mother Jones and Forbes. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 87d ago.
Quick answers
Why is "Trump may be mystery patient in odd case of 79yo getting experimental obesity dr" trending?
Because 7 independent news sources published 9 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (9)
- Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient The New Republic · 89d ago
- White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug The Daily Beast · 89d ago
- Did Trump Get Special Access to Retatrutide? Mother Jones · 89d ago
- White House Denies Trump Was Given Exclusive Weight Loss Drug Forbes · 89d ago
- Remember That Time Trump Said He “Probably Should” Take Ozempic? The New Republic · 89d ago
- Lilly allows one-time access to next-gen obesity drug (update) Seeking Alpha · 89d ago
- Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program statnews.com · 89d ago
- Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? statnews.com · 89d ago
- Trump may be mystery patient in odd case of 79yo getting experimental obesity drug Ars Technica · 89d ago
Topics
Related trends
U.S.-listed Greenland stocks surge after Trump announces security deal with Denmark
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Grassley urges Trump to place embargo on diesel exports amid high prices
Grassley urges an embargo on US diesel exports to ease surging fuel prices, drawing varied responses from lawmakers and analysts.
Yuan hits fresh multi-year peak as PBOC eases curb ahead of Trump-Xi summit
The Chinese yuan has reached its strongest level since 2022 following a crucial PBOC fixing.
Stocks advance after Bessent says talks with China were successful before Trump-Xi meeting
Stock futures climb following reports of successful talks with China ahead of the Trump-Xi meeting.
Trump, 80, Hints at Next Bonkers Move in Ominous Truth Social Post
An ominous Truth Social post and escalating territorial debates draw sharp international scrutiny and criticism.
Trump’s economist takes lying to an Olympian level on Fox News
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.